Europe risks falling further behind in medicine race, warns Roche CEO [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
pharmaceutical research and innovation because of "mind-blowing" bureaucracy and government policies ?threatening jobs, Roche Chief Executive Thomas Schinecker warned on Thursday. His comments come as drugmakers weigh the ?impact of U.S. President Donald Trump's “most-favored-nation” pricing push, which aims to tie some medicine prices in the lucrative U.S. market to lower ?prices elsewhere, including in Europe. Since the policy was launched in May last year, new drug launches in Europe have fallen by around a third, a GlobalData analysis found. "Europe is so far behind and in most industries, I'm sad to say, they've lost the race," Schinecker told Reuters, adding "illogical" regulation was holding back innovation and undermining one ?of the region's few industrial strengths. "Pharma ?is still one of the industries where they can still play, but they have to make the right decisions." Europe's pharmaceutical industry has been lobbying governments as U.S. pricing ?policies shak
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapsesGlobeNewswire
- Sanofi SA (SNY) Q1 2026 Earnings Call Highlights: Strong Sales Growth and Strategic Developments [Yahoo! Finance]Yahoo! Finance
- ???????????(ATV)?????????????????(UTV)??:???????????? [CNET News]CNET News
- Sanofi Q1 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- BNP Paribas Downgrades Sanofi (SNY) with ‘Unlikely Near-Term Rerating' [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 4/23/26 - Form 6-K
- 4/15/26 - Form 6-K
- 4/10/26 - Form SCHEDULE
- SNY's page on the SEC website